BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Tissue Science Laboratories PLC Positive Cinical Results For Permacol’R’ As A UBA

  December 5, 2005

   · 

  1 min read
• Drug Development

  OXiGENE To Commence First Ever Oncology Clinical Trial Combining A Vascular Disrupting Compound, Combretastatin A4P, With An Anti-Angiogenic Agent, Avastin

  December 5, 2005

   · 

  8 min read
• Pharm Country

  Bristol-Myers Squibb Company To Webcast December 12 Business Update

  December 5, 2005

   · 

  1 min read
• Biotech Bay

  Gilead Sciences (Foster City, CA) To Present At The NASDAQ 16th Investor Program

  December 5, 2005

   · 

  1 min read
• Policy

  TEVA Pharmaceuticals USA Announces FTC Will Not File Objections To Effexor(R) XR Settlement

  December 5, 2005

   · 

  1 min read
• FDA

  Par Pharmaceutical Companies, Inc.'s Partner Receives Final Approval To Market Ribavirin Tablets

  December 5, 2005

   · 

  2 min read
• Deals

  ID Biomedical Provides Update On Application For Court Approval Of Acquisition By GlaxoSmithKline

  December 5, 2005

   · 

  3 min read
• Policy

  Merck & Co., Inc. Submits Biologics License Application To FDA For GARDASIL(R), The Company’s Investigational Vaccine For Cervical Cancer

  December 5, 2005

   · 

  3 min read
• Biotech Beach

  La Jolla Pharmaceutical Company Continues Special Meeting Of Stockholders To December 12, 2005

  December 5, 2005

   · 

  5 min read
• Policy

  Shire Pharmaceuticals Group plc Release: FDA Psychopharmacologic Drugs Advisory Committee Supports Safety And Efficacy Of DAYTRANA(TM)

  December 5, 2005

   · 

  5 min read